[1] Carter, S.K. (1977) Clinical trials in cancer chemotherapy. Cancer, 40, 544-57.

[2] American Society of Clinical Oncology (1997) Critical role of phase I clinical trials in cancer treatment. Journal of Clinical Oncology, 15, 853-9.

[3] Therasse, P., Arbuck, S.G., Eisenhauer, E.A., Wanders, J., Kaplan, R.S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A.T., Christian, M.C., and Gwyther, S.G. (2000) New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute, 92, 205-16.

[4] Fleming, T.R. (1982) One sample multiple testing procedure for Phase II clinical trials. Biometrics, 38, 143-51.

[5] Gehan, E.A. (1961) The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent. Journal of Chronic Diseases, 13, 346-53.

[6] Simon R. (1989) Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials, 10, 1-10.

[7] Thall, P.F., and Simon, R. (1995) Recent developments in the design of phase II clinical trials. In Recent Advances in the Design and Analysis of Clinical Trials (ed. P. Thall) pp. 49-71. Kluwer, Norwell, Massachusetts.

[8] Simon, R., Wittes, R.E., and Ellenberg, S.S. (1985) Randomized phase-II clinical trials. Cancer Treatment Reports, 69(12), 1375-81.

[9] Stenning, S.P., Freedman, L.S., and Bleehen, N.M. (1990) On behalf of the MRC Brain Tumour Working Party. Prognostic factors in malignant glioma - development of a prognostic index. Journal of Neuro-Oncology, 9, 47-55.

[10] Feinstein, A.R., Sosin, D.M., and Wells, C.K. (1985) The Will Rogers phenomenon, stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New England Journal of Medicine, 312(25), 1604-08.

[11] Beyer, J., Stenning, S.P., Fossa, S.D., and Siegert, W. (2002) High dose vs conventional-dose chemotherapy as first salvage treatment in patients with non-seminomatous germ cell tumours: a matched pair analysis. Annals of Oncology, 13(4), 599-605.

[12] Schwarz, F., and Lelouche, A. (1967) Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases, 20, 637-48.

[13] Arnott, S.J., Duncan, W., Gignoux, M., Girling, D.J., Hansen, H.S., Launois, B., Nygaard, K., Parmar, M.K.B., Roussel, A., Spiliopoulos, G., Stewart, L.A., Tierney, J.F., Wang, M., and Zhang, R.G. (1998) Preoperative radiotherapy in esophageal carcinoma: A meta-analysis using individual patient data (oesophageal cancer collaborative group). International Journal of Radiation Oncology Biology Physics, 41, 579-83.

[14] Gray, R., James, R., Mossman, J., and Stenning, S.P. (1991) Guest editorial: AXIS - A suitable case for treatment. British Journal of Cancer, 63, 841-45.

[15] Stenning, S.P. for the AXIS Collaborators (1994) The AXIS colorectal cancer trial: randomization of over 2000 patients. British Journal of Surgery, 81, 1672.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment